Historically, this is a $1 share, and should return to those levels. The huge run-up was due to the hype about a private equity buyout, and the current premium to fair value is unwarranted.
- Forums
- ASX - By Stock
- buy
PTD
unknown
Historically, this is a $1 share, and should return to those...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online